| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/29/2006 | US7098183 cell growth differentiation factors/polypeptides for immunization; animal models |
| 08/29/2006 | US7098036 Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
| 08/29/2006 | US7098026 Human desert hedgehog protein |
| 08/29/2006 | US7098012 DNA demethylase, therapeutic and diagnostic uses thereof |
| 08/29/2006 | US7098006 preparation of an antibody chain having a variable domain comprising three complementarity determining regions |
| 08/29/2006 | US7098004 Isolated polypeptide of the stratum corneum and its use |
| 08/29/2006 | US7097994 UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GaINAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 08/29/2006 | US7097991 screening for an agent that modulates capsaicin receptor function |
| 08/29/2006 | US7097989 Complement C3 precursor biopolymer markers predictive of type II diabetes |
| 08/29/2006 | US7097986 For use in pharmaceutical and diagnostic formulations |
| 08/29/2006 | US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 08/29/2006 | US7097982 Peptides and compositions which modulate apoptosis |
| 08/29/2006 | US7097971 novel peptides based on conserved regions of regulatory and auxiliary HIV proteins, antigens in free or carrier-bound form comprising one of the peptides, vaccine compositions containing one of the antigens, immunoassay kits and a method of detecting antibodies, induced by HIV using such antigens |
| 08/29/2006 | US7097846 35 kD tumor associated protein antigen: uses and methods of detection |
| 08/29/2006 | US7097838 Antagonists of HMG1 for treating inflammatory conditions |
| 08/29/2006 | US7097834 Osteoprotegerin binding proteins |
| 08/29/2006 | CA2239183C Branched hydrazone linkers |
| 08/29/2006 | CA2053585C Antibody production in chinese hamster ovary cells |
| 08/24/2006 | WO2006089294A2 Tissue specific expression of antibodies in chickens |
| 08/24/2006 | WO2006089251A2 SYNERGISTIC EFFECT OF TGF-β BLOCKADE AND IMMUNOGENIC AGENTS ON TUMORS |
| 08/24/2006 | WO2006089232A2 Monoclonal antibodies against cd30 lacking fucosyl residues |
| 08/24/2006 | WO2006089231A2 Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues |
| 08/24/2006 | WO2006089230A2 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 08/24/2006 | WO2006088833A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 08/24/2006 | WO2006088700A2 Human ring specific bnp antibodies |
| 08/24/2006 | WO2006088503A1 Delivery of enzymes to the brain |
| 08/24/2006 | WO2006088494A2 Identification and engineering of antibodies with variant fc regions and methods of using the same |
| 08/24/2006 | WO2006088464A2 A method of using an anti-cd137 antibody as an agent for radioimmunotherapy or radioimmunodetection |
| 08/24/2006 | WO2006088447A1 An anti-cd137 antibody as an agent in the treatement of cancer and glycosylation variants thereof |
| 08/24/2006 | WO2006088198A1 Method of producing protein by using hamster igf-1 |
| 08/24/2006 | WO2006087637A2 Anti her2/neu antibody |
| 08/24/2006 | WO2006087533A2 Ricin-binding peptides and methods for use thereof |
| 08/24/2006 | WO2006087374A1 Diagnosis of prostate cancer |
| 08/24/2006 | WO2006087178A1 Use of activated polymers for separation of protein and polypeptide multimers |
| 08/24/2006 | WO2006086823A1 Molecules and chimeric molecules thereof |
| 08/24/2006 | WO2006060419A3 Biomarkers for pre-selection of patients for anti-igf1r therapy |
| 08/24/2006 | WO2006055638A3 Fully human monoclonal antibodies to il-13 |
| 08/24/2006 | WO2006055347A3 Desacyl ghrelin antibodies and therapeutic uses thereof |
| 08/24/2006 | WO2006028576A3 Determination of a phosphorylation site in ppiase domain of pin1 and uses therefor |
| 08/24/2006 | WO2005120571A3 Method of passive immunization against disease or disorder characterized by amyloid aggregation with diminished risk of neuroinflammation |
| 08/24/2006 | WO2004043397A3 Compositions and methods for the treatment of rheumatoid arthritis |
| 08/24/2006 | US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof |
| 08/24/2006 | US20060191026 Tissue specific expression of antibodies in chickens |
| 08/24/2006 | US20060191024 Method for preparing anti-MIF antibodies |
| 08/24/2006 | US20060189794 Ligand having agonistic activity to mutated receptor |
| 08/24/2006 | US20060189793 Methods and compositions for inhibiting neoplastic cell growth |
| 08/24/2006 | US20060189792 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 08/24/2006 | US20060189791 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 08/24/2006 | US20060189538 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 08/24/2006 | US20060189530 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 08/24/2006 | US20060189525 DADD, death activator death domain protein |
| 08/24/2006 | US20060189518 Preventing/remedies for cancer |
| 08/24/2006 | US20060188962 19 human secreted proteins |
| 08/24/2006 | US20060188957 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding |
| 08/24/2006 | US20060188516 Chlamydia trachomatis antigens |
| 08/24/2006 | US20060188512 Active immunization to generate antibodies to solble a-beta |
| 08/24/2006 | US20060188510 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 |
| 08/24/2006 | US20060188505 Treatment of autism |
| 08/24/2006 | US20060188504 Interleukin-13 as a cardiovascular disease marker |
| 08/24/2006 | US20060188502 Nucleic acid encoding a chimeric, humanized or CDR-grafted antibody that binds and inhibits the activity of human IL-6 |
| 08/24/2006 | US20060188501 Diagnostic and therapeutic agents for rheumatoid arthritis |
| 08/24/2006 | US20060188497 Immunotherapeutic combination for the treatment of tumors that over-express receptors with tyrosine kinase activity |
| 08/24/2006 | US20060188493 Use of an active substance that binds to cd28 for producing a pharmaceutical composition |
| 08/24/2006 | US20060188440 Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer |
| 08/24/2006 | US20060188439 Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection |
| 08/24/2006 | CA2598570A1 Methods for producing proteins using hamster igf-1 |
| 08/24/2006 | CA2598561A1 Monoclonal antibodies against cd30 lacking in fucosyl residues |
| 08/24/2006 | CA2598535A1 Anti her2/neu antibody |
| 08/24/2006 | CA2598522A1 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 08/24/2006 | CA2598454A1 Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues |
| 08/24/2006 | CA2598321A1 Method for differentially detecting multimeric form from monomeric form of multimer-forming polypeptides |
| 08/24/2006 | CA2598253A1 Human ring specific bnp antibodies |
| 08/24/2006 | CA2598090A1 Synergistic effect of tgf-beta blockade and immunogenic agents on tumors |
| 08/24/2006 | CA2597924A1 Anti-cd19 antibodies and uses in oncology |
| 08/24/2006 | CA2597717A1 Antibodies against cxcr4 and methods of use thereof |
| 08/24/2006 | CA2597584A1 Molecules and chimeric molecules thereof |
| 08/24/2006 | CA2597373A1 Methods and compositions for impairing multiplication of hiv-1 |
| 08/24/2006 | CA2596509A1 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 08/24/2006 | CA2595939A1 Methods of predicting therpeutic response in atopic dermatitis to il-31 antagonists |
| 08/24/2006 | CA2594666A1 Use of activated polymers for separation of protein and polypeptide multimers |
| 08/24/2006 | CA2594490A1 Methods of treating skin disorders using an il-31ra antagonist |
| 08/24/2006 | CA2573659A1 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 08/23/2006 | EP1693457A2 Metastatic breast and colon cancer regulated genes |
| 08/23/2006 | EP1693456A1 Gene encoding g protein-coupled receptor and gene product thereof |
| 08/23/2006 | EP1693448A1 Double specific antibodies substituting for functional protein |
| 08/23/2006 | EP1693386A1 Methods for producing antibody |
| 08/23/2006 | EP1693385A1 Humanized anti-cd47 antibody |
| 08/23/2006 | EP1693384A2 Functional immunoglobulins against human serum albumin, fragments thereof, library thereof and methods of production thereof |
| 08/23/2006 | EP1693383A1 Antibodies for use in identifying prostate cancer |
| 08/23/2006 | EP1693069A1 Remedy for solid tumor |
| 08/23/2006 | EP1692509A2 Methods for detecting l-ficolin dependent activation of the lectin pathway of complement and kits therefor |
| 08/23/2006 | EP1692287A1 Bacterial virulence factors and uses thereof |
| 08/23/2006 | EP1692265A2 Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins |
| 08/23/2006 | EP1692186A1 Cancer cell targeting gene delivery method |
| 08/23/2006 | EP1692185A2 Use of l-isoaspartyl methyltransferase as longevity marker in seeds |
| 08/23/2006 | EP1692184A2 Antibodies that bind interleukin-4 receptor |
| 08/23/2006 | EP1692183A2 Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia |
| 08/23/2006 | EP1692182A2 Cd20 antibodies with increased fc receptor binding affinity and effector function |
| 08/23/2006 | EP1692181A1 Leptin antagonist and method for quantitative measurement of leptin |
| 08/23/2006 | EP1692180A2 Anti-il-20 antibodies and binding partners and methods of using in inflammation |